Selected Publications

Selected Publications

  • Apostoli, AJ., Roche, JM., Schneider MM., SenGupta, SK., Di Lena, MA., Rubino, RE., Peterson, NT. and Nicol, CJ. (2015) Opposing Roles for Mammary Epithelial-Specific PPARγ Signaling and Activation During Breast Tumour Progression. Mol Cancer – 14: 85. DOI: 10.1186/s12943-015-0347-8    

  • Chung, MM, Chen, YL, Pei, D, Cheng, YC, Sun, B, Nicol, CJ, Yen, CH, Chen, HM, Liang, YJ and Chiang, MC. (2015). The neuroprotective role of metformin in advanced glycation end products treated human neural stem cells is AMPK dependent. Biochimica et Biophysica Acta - Molecular Basis of Disease – 1852: 720-731. DOI: 10.1016/j.bbadis.2015.01.006
  • Mattioli, TA., Leduc-Pessah, H., Skelhorne-Gross, GE., Nicol,  CJ., Milne, B., Trang, T. and Cahill, CM. (2014) Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence. PloS One May, 9(5): e97361. DOI: 10.1371/journal.pone.0097361.    
  • Apostoli, AJ., Skelhorne-Gross, G., Rubino, RE., Peterson, NT., Di Lena, MA., Schneider, MM., SenGupta, SK. and Nicol, CJ. (2014) Loss of PPARg expression in mammary secretory epithelial cells creates a pro-breast tumorigenic environment. Int. J. Cancer 134: 1055-1066.
  • Skelhorne-Gross, G. and Nicol, CJ. (2012). The key to unlocking the chemotherapeutic potential of PPARγ ligands: having the right combination. PPAR Res. 2012: 946943.
  • Apostoli, AJ. and Nicol, CJ. (2012) PPAR medicines and human disease: The ABCs of it all. PPAR Res., 2012: 504918. 
  • Skelhorne-Gross, G., Reid, AL., Apostoli, AJ., Di Lena, MA., Rubino, RE., Peterson, NT., Schneider, M., SenGupta, SK., Gonzalez, FJ. and Nicol, CJ. (2012) Stromal PPARγ protects against breast tumourigenesis. Carcinogenesis, 33: 1412-1420.
  • Shan, W., Nicol, CJ., Ito, S., Bility, MT., Kennett, MJ., Ward, JM., Gonzalez, FJ. and Peters, JM. (2008) Peroxisome proliferator-activated receptor-b/d protects against chemically-induced liver toxicity in mice. Hepatology, 47: 225-235.